BEIJING, April 18 (Xinhua) -- China will include more anti-cancer drugs on its new list of medicines eligible for medical insurance reimbursement to be released this year. Apart from cancer drugs, medicines for rare diseases, chronic illness, children and first-aid treatment are among the optio...
Head and neck cancers include those of the larynx (the voice box); the tongue; both the soft and hard palates; and tumors of the salivary glands, including the parotid gland.Drugs used to treat Head and Neck Cancer The medications listed below are related to or used in the treatment of...
Compare risks and benefits of common medications used for Lung Cancer. Find the most popular drugs, view ratings and user reviews.
In July last year, the Ministry of Human Resources and Social Security announced that following price negotiations, 36 drugs would be included in the national basic medical insurance program. Fifteen were cancer drugs, and their prices were...
Five cancer drugs have been reinstated on the list paid for by England's Cancer Drugs Fund, after manufacturers provided discounts to make them more affordable. The fund faces rising costs, and in September it announced the removal of 16 drugs used in 23 treatments, in an attempt to balance...
cancernetwork.com/news/asco... Personally I have no issue with these sensible suggestions, but I do have some comments. 1. Controlling any nausea resulting from chemotherapy treatment can make a huge difference to how well you get through the tre...
Medications and prescription drug information for consumers and medical health professionals. Online database of the most popular drugs and their side effects, interactions, and use.
BEIJING, Aug. 4 (Xinhua) -- China will make more cancer drugs affordable, as a new round of negotiations between the country's state medical insurance administration and pharmaceutical companies to add such drugs to the medical insurance list is scheduled to finish by...
BEIJING, Aug. 4 (Xinhua) -- China will make more cancer drugs affordable, as a new round of negotiations between the country's state medical insurance administration and pharmaceutical companies to add such drugs to the medical insurance list is scheduled to finish by the end of September. ...
this product was used for HER2 positive advanced gastric cancer or gastroesophageal junction adenocarcinoma indications that had previously failed HER2 treatment. It has just been proposed to be included in the breakthrough treatment variety by the Drug Evaluation Center of the National Medical Products ...